On March 25, 2022, Homology Medicines, Inc. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased the Company’s securities between June 10, 2019 and February 18, 2022.
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.